PATrOL-enabled NT0100 for the Treatment of Huntington's Disease KOL Lunch, hosted by Neubase

The meeting will feature a presentation by key opinion leaders George Church, MD (Harvard Medical School), and Robert Friedlander, MD, MA (University of Pittsburgh) who will discuss the current treatment landscape, as well as the unmet medical need for treating patients with Huntington's Disease.